| Literature DB >> 35807083 |
Riccardo D'Ambrosi1,2, Prem Haridas Menon3, Abhijeet Salunke4, Ilaria Mariani5, Giovanni Palminteri1,2, Giuseppe Basile1, Nicola Ursino1, Laura Mangiavini1,2, Michael Hantes6.
Abstract
PURPOSE: The primary goal of this study was to compare survivorship and functional results in individuals aged 80 and over who underwent total knee arthroplasty (TKA) with cruciate-retaining (CR) or posterior-stabilized (PS) implants.Entities:
Keywords: cruciate-retaining; knee arthroplasty; knee osteoarthritis; octogenarian; posterior-stabilized; survivorship
Year: 2022 PMID: 35807083 PMCID: PMC9267517 DOI: 10.3390/jcm11133795
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Pre- and intraoperative comparisons between groups.
| Group | |||
|---|---|---|---|
| CR | PS | ||
| Age | 82.30 ± 2.17 | 81.51 ± 1.83 | 0.063 |
| Sex, | |||
| F | 27 (73.0) | 43 (72.9) | 1.000 |
| M | 10 (27.0) | 16 (27.1) | |
| Side, | |||
| Right | 21 (56.8) | 34 (57.6) | 1.000 |
| Left | 16 (43.2) | 25 (42.4) | |
| Surgical time | 48.70 ± 7.83 | 56.19 ± 11.43 | 0.001 * |
|
| |||
| VAS | 7.46 ± 1.39 | 7.39 ± 1.26 | 0.800 |
| Flexion | 90.35 ± 8.20 | 90.36 ± 9.39 | 0.998 |
| Extension | 4.86 ± 3.22 | 4.93 ± 2.86 | 0.853 |
| KSS | 36.76 ± 9.30 | 36.75 ± 8.79 | 0.995 |
| OKS | 20.59 ± 4.13 | 20.80 ± 3.60 | 0.692 |
|
| |||
| T1 | 13.00 ± 0.97 | 12.98 ± 1.09 | 0.743 |
| T2 | 47.46 ± 12.26 | 47.35 ± 12.52 | 0.967 |
* statistically significant value p < 0.05. CR = cruciate-retaining; PS = posterior-stabilized; VAS = visual analogue scale for pain; KSS = Knee Society Score; OKS = Oxford Knee Score; T1 = minimum 1-year follow-up; T2 = minimum 2-year follow-up.
Clinical comparisons between groups at each postoperative follow-up.
| CR Group | PS Group | Group Comparison | Time Comparison Adjusted | ||||
|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | CR | PS | ||||
|
| |||||||
| T0 | 7.46 ± 1.39 ( | 7.39 ± 1.26 ( | 0.800 | T0 | T1 | T0 | T1 |
| T1 | 1.66 ± 1.39 ( | 2.05 ± 1.34 ( | 0.179 | <0.001 * | - | <0.001 * | - |
| T2 | 1.56 ± 1.33 ( | 1.53 ± 1.02 ( | 0.900 | <0.001 * | >0.99 | <0.001 * | 0.002 * |
|
| |||||||
| T0 | 90.35 ± 8.20 ( | 90.36 ± 9.39 ( | 0.998 | T0 | T1 | T0 | T1 |
| T1 | 116.14 ± 5.57 ( | 113.16 ± 7.66 ( | 0.048* | <0.001 * | - | <0.001 * | - |
| T2 | 120.00 ± 3.69 ( | 118.91 ± 4.27 ( | 0.221 | <0.001 * | 0.007 * | <0.001 * | <0.001 * |
|
| |||||||
| T0 | 4.86 ± 3.22 ( | 4.93 ± 2.86 ( | 0.853 | T0 | T1 | T0 | T1 |
| T1 | 1.14 ± 2.45 ( | 2.11 ± 2.98 ( | 0.093 | <0.001 * | - | <0.001 * | - |
| T2 | 1.18 ± 2.48 ( | 1.18 ± 2.35 ( | 0.915 | <0.001 * | >0.99 | <0.001 * | 0.014 * |
|
| |||||||
| T1 | 36.76 ± 9.30 ( | 36.75 ± 8.79 ( | 0.995 | T0 | T1 | T0 | T1 |
| T2 | 91.00 ± 5.53 ( | 89.39 ± 7.08 ( | 0.253 | <0.001 * | - | <0.001 * | - |
| T3 | 91.62 ± 5.03 ( | 91.09 ± 5.50 ( | 0.652 | <0.001 * | 0.316 | <0.001 * | 0.002 * |
|
| |||||||
| T1 | 20.59 ± 4.13 ( | 20.80 ± 3.60 ( | 0.692 | T0 | T1 | T0 | T1 |
| T2 | 43.86 ± 1.77 ( | 43.72 ± 2.03 ( | 0.588 | <0.001 * | - | <0.001 * | - |
| T3 | 44.09 ± 1.85 ( | 43.98 ± 2.26 ( | 0.772 | <0.001 * | >0.99 | <0.001 * | >0.99 |
* statistically significant value p < 0.05. CR = cruciate-retaining; PS = posterior-stabilized; VAS = visual analogue scale for pain; KSS = Knee Society Score; OKS = Oxford Knee Score; T0 = follow-up the day before surgery; T1 = minimum 1-year follow-up; T2 = minimum 2-year follow-up; T3 = minimum 3-year follow-up.
Analysis of failures and complications for both groups during the study period.
| Group | ||
|---|---|---|
| CR | PS | |
| Failures at T1 | ||
| Death | 1 (7th month) | 1 (8th month) |
| Infection | 1 (1st month) | 0 |
| Periprosthetic Fracture | 0 | 1 (12th month) |
| Failures at T2 | ||
| Death | 1 (18th month) | 2 (18th and 28th month) |
| Total number of failures | 3 | 4 |
CR = cruciate-retaining; PS = posterior-stabilized.
Analysis of survival in each study group.
| Month | Number of Patients at Risk | Number of Failures | Survival Probability % (SE) |
|---|---|---|---|
|
| |||
| 1 | 37 | 1 | 97.3 (2.67) |
| 7 | 36 | 1 | 94.6 (3.72) |
| 18 | 35 | 1 | 91.9 (4.49) |
|
| |||
| 8 | 59 | 1 | 98.3 (1.68) |
| 12 | 58 | 2 | 94.9 (2.86) |
| 18 | 56 | 1 | 93.2 (3.27) |
| Difference in survival time: chi-squared test | |||
CR = cruciate-retaining; PS = posterior-stabilized.
Figure 1Kaplan-Meier curves and survival probabilities for each group.